$QSI
Quantum-Si Inc

2023 Q3 Form 10-Q Financial Statement

#000114036123052474 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2022 Q3
Revenue $223.0K $0.00
YoY Change
Cost Of Revenue $115.0K $0.00
YoY Change
Gross Profit $108.0K $0.00
YoY Change
Gross Profit Margin 48.43%
Selling, General & Admin $10.70M $10.98M
YoY Change -2.61% -21.95%
% of Gross Profit 9903.7%
Research & Development $16.59M $16.68M
YoY Change -0.53% 50.17%
% of Gross Profit 15358.33%
Depreciation & Amortization $1.170M $729.0K
YoY Change 60.49% 176.14%
% of Gross Profit 1083.33%
Operating Expenses $27.28M $27.66M
YoY Change -1.36% 9.86%
Operating Profit -$27.18M -$27.66M
YoY Change -1.75% 9.86%
Interest Expense $2.570M $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net -$15.00K -$5.573M
YoY Change -99.73% -187.83%
Pretax Income -$24.73M -$31.71M
YoY Change -22.03% 75.3%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$24.73M -$31.71M
YoY Change -22.03% 75.3%
Net Earnings / Revenue -11088.79%
Basic Earnings Per Share -$0.17 -$0.23
Diluted Earnings Per Share -$0.17 -$0.23
COMMON SHARES
Basic Shares Outstanding 141.7M 139.5M
Diluted Shares Outstanding 141.7M 139.5M

Balance Sheet

Concept 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $274.6M $372.1M
YoY Change -26.2% -25.62%
Cash & Equivalents $93.82M $78.26M
Short-Term Investments $180.8M $293.8M
Other Short-Term Assets $7.400M $6.799M
YoY Change 8.84% 36.06%
Inventory $2.325M
Prepaid Expenses
Receivables $466.0K
Other Receivables $0.00
Total Short-Term Assets $284.8M $378.9M
YoY Change -24.83% -25.01%
LONG-TERM ASSETS
Property, Plant & Equipment $17.61M $13.76M
YoY Change 27.91% 227.17%
Goodwill $9.483M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $701.0K $697.0K
YoY Change 0.57% 495.73%
Total Long-Term Assets $33.29M $39.11M
YoY Change -14.89% 804.49%
TOTAL ASSETS
Total Short-Term Assets $284.8M $378.9M
Total Long-Term Assets $33.29M $39.11M
Total Assets $318.1M $418.0M
YoY Change -23.9% -17.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.056M $1.775M
YoY Change 15.83% -44.04%
Accrued Expenses $9.000M $10.87M
YoY Change -17.17% 170.03%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $11.01M $12.64M
YoY Change -12.93% 75.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $19.00K $0.00
YoY Change -100.0%
Total Long-Term Liabilities $19.00K $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.01M $12.64M
Total Long-Term Liabilities $19.00K $0.00
Total Liabilities $26.03M $30.53M
YoY Change -14.74% 95.59%
SHAREHOLDERS EQUITY
Retained Earnings -$473.6M -$366.5M
YoY Change 29.21%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $292.1M $387.5M
YoY Change
Total Liabilities & Shareholders Equity $318.1M $418.0M
YoY Change -23.9% -17.97%

Cashflow Statement

Concept 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$24.73M -$31.71M
YoY Change -22.03% 75.3%
Depreciation, Depletion And Amortization $1.170M $729.0K
YoY Change 60.49% 176.14%
Cash From Operating Activities -$21.45M -$21.80M
YoY Change -1.62% 13.31%
INVESTING ACTIVITIES
Capital Expenditures $1.380M -$1.779M
YoY Change -177.57% 58.13%
Acquisitions
YoY Change
Other Investing Activities $28.50M $18.95M
YoY Change 50.41% -104.32%
Cash From Investing Activities $27.12M $17.17M
YoY Change 57.96% -103.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 210.0K 1.625M
YoY Change -87.08% -322.6%
NET CHANGE
Cash From Operating Activities -21.45M -21.80M
Cash From Investing Activities 27.12M 17.17M
Cash From Financing Activities 210.0K 1.625M
Net Change In Cash 5.880M -3.009M
YoY Change -295.41% -99.35%
FREE CASH FLOW
Cash From Operating Activities -$21.45M -$21.80M
Capital Expenditures $1.380M -$1.779M
Free Cash Flow -$22.83M -$20.02M
YoY Change 14.01% 10.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16587000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10696000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
31093000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
27283000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-27175000
CY2023Q3 us-gaap Investment Income Dividend
InvestmentIncomeDividend
2572000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24728000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-31713000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
139542660
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
8000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3063000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1789000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5121000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-400000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
141000
qsi Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
83000
qsi Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
9466000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-732000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-444000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-2656000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2224000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1995000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
8976000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-73067000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7241000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
834000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
88000000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
119759000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
82360000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
111684000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
357000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2619000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
9503000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
50588000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53905000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
27658000
us-gaap Operating Expenses
OperatingExpenses
83598000
us-gaap Operating Income Loss
OperatingIncomeLoss
-83288000
us-gaap Operating Income Loss
OperatingIncomeLoss
-84998000
CY2022Q3 us-gaap Investment Income Dividend
InvestmentIncomeDividend
1381000
us-gaap Investment Income Dividend
InvestmentIncomeDividend
7274000
us-gaap Investment Income Dividend
InvestmentIncomeDividend
3288000
CY2023Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-162000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
370000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-24728000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24728000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31713000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-73912000
us-gaap Net Income Loss
NetIncomeLoss
-73912000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-99302000
us-gaap Net Income Loss
NetIncomeLoss
-99302000
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35785000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93822000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78263000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
141154110
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-27658000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16675000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
139057663
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
139057663
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1388175
dei Entity Address Address Line1
EntityAddressAddressLine1
29 Business Park Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Branford
dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06405
dei City Area Code
CityAreaCode
866
dei Local Phone Number
LocalPhoneNumber
688-7374
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
627000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13928000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16077000
us-gaap Net Income Loss
NetIncomeLoss
-73912000
us-gaap Net Income Loss
NetIncomeLoss
-99302000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1486000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1273000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
81000
us-gaap Share Based Compensation
ShareBasedCompensation
6914000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2325000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
236000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
931000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
19000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-70977000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4877000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
763000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
210000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1771000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
84319000
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
223000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
682000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
115000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
0
us-gaap Cost Of Revenue
CostOfRevenue
372000
us-gaap Operating Expenses
OperatingExpenses
84998000
CY2022Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
137000
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-81000
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
5121000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-15000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
70000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-31713000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-73912000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
139542660
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
141154110
us-gaap Share Based Compensation
ShareBasedCompensation
7099000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
466000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
7000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
348000
qsi Payment For Deferred Consideration
PaymentForDeferredConsideration
0
qsi Payment For Deferred Consideration
PaymentForDeferredConsideration
500000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
59000
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001816431
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3M
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
qsi Standard Product Warranty Warranty Period
StandardProductWarrantyWarrantyPeriod
P12M
CY2020Q3 qsi Number Of Warrants Issued Per Unit Issued
NumberOfWarrantsIssuedPerUnitIssued
0.33
dei Document Type
DocumentType
10-Q
dei Entity File Number
EntityFileNumber
001-39486
dei Entity Registrant Name
EntityRegistrantName
QUANTUM-SI INCORPORATED
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Cost Of Revenue
CostOfRevenue
0
CY2023Q3 us-gaap Gross Profit
GrossProfit
108000
CY2022Q3 us-gaap Gross Profit
GrossProfit
0
us-gaap Gross Profit
GrossProfit
310000
us-gaap Gross Profit
GrossProfit
0
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10983000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
33010000
CY2023Q3 us-gaap Debt Securities Trading Unrealized Gain Loss
DebtSecuritiesTradingUnrealizedGainLoss
1953000
CY2022Q3 us-gaap Debt Securities Trading Unrealized Gain Loss
DebtSecuritiesTradingUnrealizedGainLoss
-4240000
us-gaap Debt Securities Trading Unrealized Gain Loss
DebtSecuritiesTradingUnrealizedGainLoss
8302000
us-gaap Debt Securities Trading Unrealized Gain Loss
DebtSecuritiesTradingUnrealizedGainLoss
-20384000
CY2023Q3 us-gaap Debt Securities Trading Realized Gain Loss
DebtSecuritiesTradingRealizedGainLoss
-1901000
CY2022Q3 us-gaap Debt Securities Trading Realized Gain Loss
DebtSecuritiesTradingRealizedGainLoss
-1348000
us-gaap Debt Securities Trading Realized Gain Loss
DebtSecuritiesTradingRealizedGainLoss
-6489000
us-gaap Debt Securities Trading Realized Gain Loss
DebtSecuritiesTradingRealizedGainLoss
-2399000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-99302000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.71
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
141660018
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
141660018
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
358706000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-23611000
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3908000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
339003000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-25573000
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1865000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
315295000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-24728000
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
357000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1141000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
292065000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
477034000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-35175000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
730000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-714000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
441875000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-32414000
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
264000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3770000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
413495000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-31713000
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1625000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4043000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
387450000
us-gaap Debt Securities Trading Unrealized Gain Loss
DebtSecuritiesTradingUnrealizedGainLoss
8302000
us-gaap Debt Securities Trading Unrealized Gain Loss
DebtSecuritiesTradingUnrealizedGainLoss
-20384000
us-gaap Debt Securities Trading Realized Gain Loss
DebtSecuritiesTradingRealizedGainLoss
-6489000
us-gaap Debt Securities Trading Realized Gain Loss
DebtSecuritiesTradingRealizedGainLoss
-2399000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-9000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
147000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
42478000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
798000
qsi Deferred Offering Costs Payable
DeferredOfferingCostsPayable
136000
qsi Deferred Offering Costs Payable
DeferredOfferingCostsPayable
0
qsi Standard Product Warranty Warranty Period
StandardProductWarrantyWarrantyPeriod
P12M
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1030000
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1285000
us-gaap Inventory Write Down
InventoryWriteDown
0
CY2023Q3 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P2Y
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
90000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
136000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
95000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
382000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
150000
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
189000
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.74
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.26
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
73000
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
71000
CY2023Q3 us-gaap Debt Securities Trading Unrealized Gain Loss
DebtSecuritiesTradingUnrealizedGainLoss
1953000
CY2022Q3 us-gaap Debt Securities Trading Unrealized Gain Loss
DebtSecuritiesTradingUnrealizedGainLoss
-4240000
us-gaap Debt Securities Trading Unrealized Gain Loss
DebtSecuritiesTradingUnrealizedGainLoss
8302000
us-gaap Debt Securities Trading Unrealized Gain Loss
DebtSecuritiesTradingUnrealizedGainLoss
-20384000
CY2023Q3 us-gaap Debt Securities Trading Realized Gain Loss
DebtSecuritiesTradingRealizedGainLoss
-1901000
CY2022Q3 us-gaap Debt Securities Trading Realized Gain Loss
DebtSecuritiesTradingRealizedGainLoss
-1348000
us-gaap Debt Securities Trading Realized Gain Loss
DebtSecuritiesTradingRealizedGainLoss
-6489000
us-gaap Debt Securities Trading Realized Gain Loss
DebtSecuritiesTradingRealizedGainLoss
-2399000
CY2023Q3 us-gaap Investment Income Dividend
InvestmentIncomeDividend
2572000
CY2022Q3 us-gaap Investment Income Dividend
InvestmentIncomeDividend
1381000
us-gaap Investment Income Dividend
InvestmentIncomeDividend
7274000
us-gaap Investment Income Dividend
InvestmentIncomeDividend
3288000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26758000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23052000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9152000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6203000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17606000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16849000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1080000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
729000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2927000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1789000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3191000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5548000
CY2023Q3 qsi Accrued Contracted Services Current
AccruedContractedServicesCurrent
2325000
CY2022Q4 qsi Accrued Contracted Services Current
AccruedContractedServicesCurrent
3616000
CY2023Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
551000
CY2022Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
0
CY2023Q3 qsi Accrued Acquisition Related Fees Current
AccruedAcquisitionRelatedFeesCurrent
0
CY2022Q4 qsi Accrued Acquisition Related Fees Current
AccruedAcquisitionRelatedFeesCurrent
343000
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
997000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
839000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
364000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
88000
CY2023Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
7428000
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
10434000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
864000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
819000
us-gaap Operating Lease Cost
OperatingLeaseCost
2613000
us-gaap Operating Lease Cost
OperatingLeaseCost
2352000
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
545000
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
321000
us-gaap Variable Lease Cost
VariableLeaseCost
1226000
us-gaap Variable Lease Cost
VariableLeaseCost
922000
CY2023Q3 us-gaap Lease Cost
LeaseCost
1409000
CY2022Q3 us-gaap Lease Cost
LeaseCost
1140000
us-gaap Lease Cost
LeaseCost
3839000
us-gaap Lease Cost
LeaseCost
3274000
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y7M6D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y3M18D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.079
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.079
us-gaap Operating Lease Payments
OperatingLeasePayments
3201000
us-gaap Operating Lease Payments
OperatingLeasePayments
1362000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
83000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9466000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1097000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4436000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4527000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4585000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4549000
CY2023Q3 qsi Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
13027000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
32221000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7666000
CY2023Q3 qsi Lease Incentives
LeaseIncentives
9104000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
15451000
CY2022Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
139542660
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
141154110
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
139057663
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
141660018
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
141660018
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
139542660
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1141000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4043000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6914000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7099000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-24728000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-31713000
us-gaap Net Income Loss
NetIncomeLoss
-73912000
us-gaap Net Income Loss
NetIncomeLoss
-99302000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-24728000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-24728000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-31713000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-31713000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-73912000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-73912000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-99302000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-99302000
CY2023Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
141660018
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
139542660
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
141154110
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
141154110
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
139057663
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
139057663
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.71
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
28230821
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18298331
CY2023Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1077000
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
996000
CY2023Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-162000
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-81000
CY2022Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
137000
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
5121000
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
2251000
us-gaap Restructuring Charges
RestructuringCharges
4131000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2023Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2022Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0

Files In Submission

Name View Source Status
0001140361-23-052474-index-headers.html Edgar Link pending
0001140361-23-052474-index.html Edgar Link pending
0001140361-23-052474.txt Edgar Link pending
0001140361-23-052474-xbrl.zip Edgar Link pending
ef20012481_10q.htm Edgar Link pending
ef20012481_ex31-1.htm Edgar Link pending
ef20012481_ex31-2.htm Edgar Link pending
ef20012481_ex32-1.htm Edgar Link pending
ef20012481_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qsi-20230930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
qsi-20230930_cal.xml Edgar Link unprocessable
qsi-20230930_def.xml Edgar Link unprocessable
qsi-20230930_lab.xml Edgar Link unprocessable
qsi-20230930_pre.xml Edgar Link unprocessable
ef20012481_10q_htm.xml Edgar Link completed
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending